Tag: Cancer: Lung
Removing Race Correction From Lung Function Test Changes Clinical Management
Removal of race correction was tied to a significant reduction in the estimation of lung function for African Americans
Common Cancer Screenings May Not Extend Life Longevity
Meta-analysis only shows a 110-day survival benefit for colorectal cancer screening with sigmoidoscopy
Cancer Screening Has Provided Significant Value to U.S. Population
Single-site cancer screening could save an additional 3.2 to 5.1 million life-years with perfect adherence
Atezolizumab Monotherapy Beneficial for NSCLC Ineligible for Platinum-Based Chemo
First-line atezolizumab monotherapy is associated with improved overall survival compared with single-agent chemotherapy
Plasma ctDNA Genotyping Can Accelerate Time to Treatment for NSCLC
Median time to treatment was 39 days for ACCELERATE cohort versus 62 days for reference cohort using standard tissue genotyping
Blood-Based Marker Plus PLCO Risk Model Can ID Lethal Lung Cancer
AUROC estimate of four-marker protein panel plus PLCOm2012 was 0.88 for risk prediction of lung cancer death
2019 to 2021 Saw Rise in Lung Cancer Screenings
Yet, variation in uptake seen by geography, race, smoking history, and age
Fewer Black Veterans Complete Referrals for Lung Cancer Screening
Black veterans had 34 percent lower odds of screening completion versus White veterans
Alectinib Exposure Lower With Low-Fat Yogurt Intake
More patients taking alectinib with low-fat yogurt do not reach the exposure threshold of 435 ng/mL
ASCO: Lack of Benefit Seen for Indefinite-Duration Immunotherapy in NSCLC
Lack of significant overall survival advantage seen for indefinite-duration versus fixed-duration immunotherapy
